Welcome to the Anti-phospholipid (APL) Syndrome Pre Activity assessment
Thank you and congratulations for attending this educational activity. Remember, continuous professional development is key to success and professional excellence.
Thank you
Anti-phospholipid (APL) Syndrome Pre
Quiz Summary
0 of 6 questions completed
Questions:
Information
|
You must fill out this field. |
|
|
You must fill out this field. |
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
Results
Results
0 of 6 questions answered correctly
Your time:
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
| Average score |
|
| Your score |
|
Categories
- Not categorized 0%
-
Thank you for taking part in this educational activity. Please make sure you filled the Survey from the link above
- 1
- 2
- 3
- 4
- 5
- 6
- Current
- Review
- Answered
- Correct
- Incorrect
-
Question 1 of 6
1. Question
1 point(s)Anti- B2 glycoprotien (anti- B2GPI) gene contributes for more than 90% of the antibody binding activity in antiphospholipid patients
CorrectIncorrect -
Question 2 of 6
2. Question
3 point(s)Which of the following are possible clinical manifestations of APL syndrome? [select all that applies]
CorrectIncorrect -
Question 3 of 6
3. Question
1 point(s)Which of the following patients can be diagnosed with APS?
CorrectIncorrect -
Question 4 of 6
4. Question
1 point(s)Heparin followed by warfarin is suggested in patient with aPL associated myocardial infarction
CorrectIncorrect -
Question 5 of 6
5. Question
1 point(s)Aspirin is considered first line treatment for patients with thrombotic events secondary to antiphospholipid syndrome
CorrectIncorrect -
Question 6 of 6
6. Question
1 point(s)When using warfarin, 2.5- 3.5 is the INR target for patients with antiphospholipid syndrome?
CorrectIncorrect